OtherArticle
Identification of the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) as a new target of cisplatin in breast cancer cells: molecular and cellular mechanisms of inhibition
Nilusha Ragunathan, Julien Dairou, Benjamin Pluvinage, Marta Martins, Emile Petit, Nathalie Janel, Jean-Marie Dupret and Fernando Rodrigues-Lima
Molecular Pharmacology February 29, 2008, DOI: https://doi.org/10.1124/mol.108.045328
Nilusha Ragunathan
Julien Dairou
Benjamin Pluvinage
Marta Martins
Emile Petit
Nathalie Janel
Jean-Marie Dupret
Fernando Rodrigues-Lima
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Molecular Pharmacology
Vol. 105, Issue 4
1 Apr 2024
OtherArticle
Identification of the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) as a new target of cisplatin in breast cancer cells: molecular and cellular mechanisms of inhibition
Nilusha Ragunathan, Julien Dairou, Benjamin Pluvinage, Marta Martins, Emile Petit, Nathalie Janel, Jean-Marie Dupret and Fernando Rodrigues-Lima
Molecular Pharmacology February 29, 2008, DOI: https://doi.org/10.1124/mol.108.045328
OtherArticle
Identification of the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) as a new target of cisplatin in breast cancer cells: molecular and cellular mechanisms of inhibition
Nilusha Ragunathan, Julien Dairou, Benjamin Pluvinage, Marta Martins, Emile Petit, Nathalie Janel, Jean-Marie Dupret and Fernando Rodrigues-Lima
Molecular Pharmacology February 29, 2008, DOI: https://doi.org/10.1124/mol.108.045328
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement